Neoleukin Therapeutics Inc (NLTX): Neoleukin Therapeuti (NLTX) 3.28 ? 0.11...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	3155
Posts	961250
Boards Moderated	204
Alias Born	09/04/2000

mick

Re: None

Sunday, 02/06/2022 4:48:29 PM

Sunday, February 06, 2022 4:48:29 PM

Neoleukin Therapeuti (NLTX)
3.28 ? 0.11 (3.47%)
Volume: 230,741 @02/04/22 4:00:57 PM EST
Bid Ask Day's Range
2.68 3.29 3.1 - 3.32
NLTX Detailed Quote

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent NLTX News

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/26/2024 06:34:31 PM
Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/26/2024 06:33:59 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/26/2024 06:33:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2024 08:44:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2024 07:43:33 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2024 08:10:58 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/18/2024 08:04:38 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/15/2024 12:54:55 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/15/2024 12:53:21 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/15/2024 12:51:43 AM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 09:29:25 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:20:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 12:30:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:07:08 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/20/2024 09:16:50 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 11:05:00 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:26:22 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 09:16:35 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:08:52 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:19:20 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/06/2024 09:18:30 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 12:01:01 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 11:58:27 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 11:56:12 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 11:53:15 PM

More NLTX News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover